Leadership & Advisory Boards

Mark McDonald

President, Ethical Review Division, WCG

Tim Schuckman

Chief Commercial Officer, Ethical Review Division, WCG

Matt Staves

Sr. Vice President of Operations

David Forster, JD, MA, CIP

Chief Compliance Officer, WCG

David A. Borasky, MPH, CIP

Vice President, IRB Compliance

Currien MacDonald, MD, CIP

IRB Chair, WCG IRB

Kelly Fitzgerald, PhD

IRB Executive Chair and VP IBC Affairs

Amy Heimberger, MD

Northwestern University Feinberg School of Medicine

Arnold J. Levine, PhD

Professor Emeritus, Institute for Advanced Study, School of Natural Sciences

George Demetri, MD

Dana-Farber Cancer Institute

Howard Scher, MD

Memorial Sloan Kettering Cancer Center

James Rothman, PhD

Yale University; Recipient, Nobel Prize in Medicine, 2013

John E. Niederhuber, MD

Former CEO, Inova Translational Medicine Institute, Former Head of the National Cancer Institute

Arnold J. Levine, PhD

Professor Emeritus, Institute for Advanced Study, School of Natural Sciences

Carl June, MD

Richard W. Vague Professor In Immunotherapy, University of Pennsylvania

Hans-Peter Kiem, MD, Dr. MED

Endowed Chair for Cell and Gene Therapy, Fred Hutch; Professor of Medicine, University of Washington

Mark Bagarazzi, MD

Chief Medical Officer, Neuvogen

Tony Reid, MD, PhD

Professor of Medicine, University of California, San Diego